The Journal of Organic Chemistry
Article
Isobutyrophenone (2h; Commercially Available). Colorless oil
(method A, 70.9 mg, 96%; method B, 69.8 mg, 94%). H NMR (400
2,2-Dimethyl-3-undecanone (2r).17a Colorless oil (method A, 97.5
mg, 98%; method B, 86.2 mg, 87%). H NMR (400 MHz, CDCl3): δ
1
1
MHz, CDCl3): δ 1.22 (d, J = 6.9 Hz, 6H), 3.56 (sept, J = 6.9 Hz, 1H),
7.46 (t, J = 7.3 Hz, 2H), 7.55 (t, J = 7.3 Hz, 1H), 7.96 (d, J = 7.3 Hz,
2H). 13C NMR (100 MHz, CDCl3): δ 19.2 (2C), 35.4, 128.4 (2C),
128.7 (2C), 132.9, 136.3, 204.6. IR (neat): 2972, 1684, 1465, 1383,
1225, 1161 cm−1.
0.88 (t, J = 7.0 Hz, 3H), 1.13 (s, 9H), 1.20−1.34 (m, 10H), 1.54 (quin,
J = 7.3 Hz, 2H), 2.47 (t, J = 7.3 Hz, 2H). 13C NMR (100 MHz,
CDCl3): δ 14.1, 22.6, 23.9, 26.4 (3C), 29.2, 29.3, 29.5, 31.8, 36.4, 44.1,
216.2. IR (neat): 2925, 1707, 1465, 1365, 1124, 1072 cm−1.
Ethyl Phenylglyoxylate (2s; Commercially Available). Colorless oil
(method A, 83.1 mg, 93%; method B, 88.6 mg, >99%). 1H NMR (400
MHz, CDCl3): δ 1.42 (t, J = 7.3 Hz, 2H), 4.46 (q, J = 7.3 Hz, 2H),
7.51 (t, J = 7.6 Hz, 2H), 7.66 (t, J = 7.6 Hz, 1H), 8.01 (d, J = 7.6 Hz,
2H). 13C NMR (100 MHz, CDCl3): δ 14.0, 62.3, 128.8 (2C), 130.0
(2C), 132.4, 134.8, 163.8, 186.4. IR (neat): 1733, 1686, 1300, 1198,
1175, 1013 cm−1.
Decyl Pyruvate (2t). Colorless oil (method A, 109.5 mg, 96%;
method B, 113.9 mg, >99%). 1H NMR (400 MHz, CDCl3): δ 0.88 (t,
J = 6.9 Hz, 3H), 1.23−1.42 (m, 14H), 1.73 (quin, J = 6.9 Hz, 2H),
2.47 (s, 3H), 4.25 (t, J = 6.9 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ
14.0, 22.6, 25.7, 26.7, 28.3, 29.1, 29.2, 29.40, 29.43, 31.8, 66.6, 160.8,
192.0. IR (neat): 2925, 1756, 1730, 1467, 1299, 1136 cm−1. MS (ESI)
calcd for C13H24NaO3 [M + Na]+ 251.1618, found 251.1617.
3-Acetoxypropiophenone (2u). Colorless oil (method A, 85.3 mg,
89%; method B, 85.7 mg, 89%). 1H NMR (400 MHz, CDCl3): δ 2.04
(s, 3H), 3.33 (t, J = 6.4 Hz, 2H), 4.53 (t, J = 6.4 Hz, 2H), 7.49 (t, J =
7.6 Hz, 2H), 7.59 (t, J = 7.6 Hz, 1H), 7.95−7.99 (m, 2H). 13C NMR
(100 MHz, CDCl3): δ 20.9, 37.3, 59.6, 128.0 (2C), 128.6 (2C), 133.4,
136.5, 171.0, 196.9. IR (KBr) 2984, 1731, 1671, 1372, 1255, 1214
cm−1. MS (ESI) calcd for C11H12NaO3 [M + Na]+ 215.0679, found
215.0679.
Pivalophenone (2i; Commercially Available). Colorless oil
1
(method A, 81.0 mg, >99%; method B, 80.7 mg, >99%). H NMR
(400 MHz, CDCl3): δ 1.35 (s, 9H), 7.39 (tt, J = 7.3, 1.6 Hz, 2H), 7.45
(tt, J = 7.3, 1.6 Hz, 1H), 7.68 (dt, J = 7.3, 1.6 Hz, 2H). 13C NMR (100
MHz, CDCl3): δ 27.9 (3C), 44.1, 127.8 (2C), 128.0 (2C), 130.7,
138.5, 209.2. IR (neat): 2969, 1674, 1476, 1366, 1277, 1175 cm−1.
Benzophenone (2j; Commercially Available). White solid (method
1
A, 90.9 mg, >99%; method B, 90.7 mg, >99%). H NMR (400 MHz,
CDCl3): δ 7.49 (t, J = 7.8 Hz, 4H), 7.60 (t, J = 7.8 Hz, 2H), 7.81 (d, J
= 7.8 Hz, 4H). 13C NMR (100 MHz, CDCl3): δ 128.2 (4C), 130.0
(4C), 132.2 (2C), 137.6 (2C), 196.7. IR (KBr) 3055, 1652, 1596,
1319, 1278 cm−1.
α-Tetralone (2k; Commercially Available). Colorless oil (method
A, 64.7 mg, 89%). 1H NMR (400 MHz, CDCl3): δ 2.14 (quin, J = 6.4
Hz, 2H), 2.66 (t, J = 6.4 Hz, 2H), 2.97 (t, J = 6.4 Hz, 2H), 7.25 (d, J =
7.6 Hz, 1H), 7.30 (t, J = 8.0 Hz, 1H), 7.47 (td, J = 7.6, 1.4 Hz, 1H),
8.03 (dd, J = 8.0, 1.4 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 23.4,
29.7, 39.1, 126.6, 127.1, 128.7, 132.6, 133.4, 144.4, 198.4. IR (neat):
2944, 1679, 1600, 1324, 1284 cm−1.
2-Octanone (2l; Commercially Available). Colorless oil (method
1
A, 64.0 mg, >99%; method B, 54.3 mg, 85%). H NMR (400 MHz,
CDCl3): δ 0.88 (t, J = 6.9 Hz, 3H), 1.24−1.36 (m, 6H), 1.52−1.62 (m,
2H), 2.13 (s, 3H), 2.42 (t, J = 7.6 Hz, 2H). 13C NMR (100 MHz,
CDCl3): δ 14.0, 22.4, 23.8, 28.8, 29.8, 31.5, 43.7, 209.3. IR (neat):
2928, 1715, 1410, 1359, 1226, 1164 cm−1.
4-Chlorobutyrophenone (2v; Commercially Available). Colorless
oil (method A, 91.1 mg, >99%; method B, 82.5 mg, 90%). H NMR
1
(400 MHz, CDCl3): δ 2.23 (quin, J = 6.8 Hz, 2H), 3.18 (t, J = 6.8 Hz,
2H), 3.68 (t, J = 6.8 Hz, 2H), 7.44−7.51 (m, 2H), 7.57 (tt, J = 7.4, 1.4
Hz, 1H), 7.98 (dd, J = 8.3, 1.4 Hz, 2H). 13C NMR (100 MHz,
CDCl3): δ 26.7, 35.2, 44.6, 127.9 (2C), 128.6 (2C), 133.2, 136.6,
198.9. IR (neat): 1683, 1448, 1322, 1225, 742, 688 cm−1.
Cyclododecanone (2m; Commercially Available). White solid
1
(method A, 91.0 mg, >99%; method B, 90.7 mg, >99%). H NMR
(400 MHz, CDCl3): δ 1.22−1.37 (m, 14H), 1.67−1.76 (m, 4H),
2.44−2.49 (m, 4H). 13C NMR (100 MHz, CDCl3): δ 22.3, 22.5 (2C),
24.2 (2C), 24.6 (2C), 24.7 (2C), 40.3 (2C), 212.9. IR (neat): 2927,
1702, 1470, 1362, 1204, 1131 cm−1.
5-Phenyl-2-pentanone (2x).17b White solid (method A, 63.2 mg,
78%; method B, 66.2 mg, 87%). 1H NMR (400 MHz, CDCl3): δ 1.91
(quin, J = 7.5 Hz, 2H), 2.11 (s, 3H), 2.43 (t, J = 7.5 Hz, 2H), 2.62 (t, J
= 7.5 Hz, 2H), 7.14−7.22 (m, 3H), 7.28 (t, J = 7.3 Hz, 2H). 13C NMR
(100 MHz, CDCl3): δ 25.1, 29.9, 34.9, 42.8, 125.9, 128.3 (2C), 128.4
(2C), 141.5, 208.8. IR (neat): 1712, 1496, 1453, 1358, 1159 cm−1.
4-Methylbenzoic Acid (4a; Commercially Available). White solid
4-tert-Butylcyclohexanone (2n; Commercially Available). White
1
solid (method A, 67.1 mg, 87%; method B, 41.3 mg, 54%). H NMR
(400 MHz, CDCl3): δ 0.92 (s, 9H), 1.38−1.55 (m, 3H), 2.03−2.15
(m, 2H), 2.25−2.36 (m, 2H), 2.36−2.45 (m, 2H). 13C NMR (100
MHz, CDCl3): δ 27.4 (5C), 32.4, 41.2 (2C), 46.6, 212.5. IR (neat):
2947, 1722, 1419, 1365, 1222, 1161 cm−1.
1
(method A, 45.8 mg, 67%; method B, 47.2 mg, 69%). H NMR (400
MHz, CDCl3): δ 2.43 (s, 3H), 7.28 (d, J = 8.2 Hz, 2H), 8.01 (d, J = 8.2
Hz, 2H), 12.20 (brs, 1H). 13C NMR (100 MHz, CDCl3): δ 21.8,
126.5, 129.2 (2C), 130.2 (2C), 144.6, 172.4. IR (neat): 2823, 1668,
1610, 1416, 1281, 1181 cm−1.
(−)-Menthone (2o; Commercially Available). Colorless oil
1
(method A, 47.9 mg, 62%). H NMR (400 MHz, CDCl3): δ 0.85
(d, J = 6.8 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H), 1.01 (d, J = 6.4 Hz, 3H),
1.28−1.45 (m, 2H), 1.78−1.93 (m, 2H), 1.99 (td, J = 12.8, 1.2 Hz,
1H), 2.01−2.09 (m, 2H), 2.09−2.21 (m, 1H), 2.35 (ddd, J = 12.8, 3.9,
2.3 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 18.7, 21.2, 22.3, 25.8,
27.8, 33.9, 35.5, 50.8, 55.9, 212.5. IR (neat): 2955, 1708, 1456, 1366,
1202, 1045 cm−1.
4-Fluorobenzoic Acid (4b; Commercially Available). White solid
1
(method A, 63.7 mg, 91%; method B, 63.7 mg, 91%). H NMR (400
MHz, DMSO-d6): δ 3.34 (brs, 1H), 7.31 (t, J = 9.1 Hz, 2H), 7.99 (dd,
J = 9.1, 5.6 Hz, 2H). 13C NMR (100 MHz, DMSO-d6): δ 115.6 (d, J =
22.0 Hz, 2C), 127.4 (d, J = 2.9 Hz), 132.1 (d, J = 9.6 Hz, 2C), 164.9
(d, J = 252.0 Hz), 166.4. 19F NMR (471 MHz, DMSO-d6) d −106.8.
IR (neat): 2828, 1672, 1603, 1425, 1291, 1157 cm−1.
5α-Cholestan-3-one (2p; Commercially Available). White solid
1
(method A, 174.8 mg, 90%; method B, 141.5 mg, 73%). H NMR
(400 MHz, CDCl3): δ 0.68 (s, 3H), 0.67−0.77 (m, 1H), 0.86 (d, J =
6.6 Hz, 3H), 0.87 (d, J = 6.6 Hz, 3H), 0.90 (d, J = 6.6 Hz, 3H), 1.01 (s,
3H), 0.93−1.19 (m, 9H), 1.19−1.44 (m, 9H), 1.46−1.62 (m, 4H),
1.69 (dq, J = 13.1, 3.4 Hz, 1H), 1.76−1.89 (m, 1H), 1.95−2.12 (m,
3H), 2.27 (t, J = 14.6 Hz, 2H), 2.27−2.44 (m, 1H). 13C NMR (100
MHz, CDCl3): δ 11.5, 12.0 18.6, 21.4, 22.5, 22.8, 23.8, 24.2, 28.0, 28.2,
28.9, 31.7, 35.4, 35.6, 35.8, 36.1, 38.2, 38.5, 39.5, 39.9, 42.5, 44.7, 46.7,
53.7, 56.21, 56.24, 212.3. IR (neat): 2930, 1712, 1466, 1383, 1229,
1173 cm−1.
4-Chlorobenzoic Acid (4c; Commercially Available). White solid
(method A, 78.1 mg, >99%; method B, 75.4 mg, 96%). 1H NMR (400
MHz, CDCl3): δ 3.35 (brs, 1H), 7.58 (d, J = 8.6 Hz, 2H), 7.94 (d, J =
8.6 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 128.8 (2C), 129.6,
131.2 (2C), 137.8, 166.5. IR (KBr) 2839, 1685, 1592, 1425, 1324,
1092 cm−1.
3-Chlorobenzoic Acid (4d; Commercially Available). White solid
(method A, 78.1 mg, >99%; method B, 75.2 mg, 96%). 1H NMR (400
MHz, CDCl3): δ 7.44 (t, J = 8.0 Hz, 1H), 7.60 (ddd, J = 8.0, 2.0, 1.2
Hz, 1H), 8.01 (dt, J = 8.0, 1.2 Hz, 1H), 8.10 (t, J = 8.0, 2.0 Hz, 1H),
11.20 (brs, 1H). 13C NMR (100 MHz, CDCl3): δ 128.3, 129.9, 130.3,
130.9, 133.9, 134.7, 170.7. IR (neat): 2882, 1682, 1415, 1299, 1260,
1074 cm−1.
(−)-Camphor (2q; Commercially Available). White solid (method
1
A, 59.7 mg, 78%; method B, 66.2 mg, 87%). H NMR (400 MHz,
CDCl3): δ 0.84 (s, 3H), 0.91 (s, 3H), 0.96 (s, 3H), 1.29−1.46 (m,
2H), 1.69 (td, J = 13.2, 3.9 Hz, 1H), 1.85 (d, J = 18.3 Hz, 1H), 1.90−
2.01 (m, 1H), 2.09 (t, J = 4.5 Hz, 1H), 2.35 (dt, J = 18.3, 4.5 Hz, 1H).
13C NMR (100 MHz, CDCl3): δ 9.2, 19.1, 19.8, 27.0, 29.9, 43.0, 43.3,
46.8, 57.7, 219.7. IR (neat): 2958, 1739, 1448, 1390, 1277, 1045 cm−1.
2-Chlorobenzoic Acid (4e; Commercially Available). White solid
1
(method A, 78.1 mg, >99%; method B, 77.9 mg, >99%). H NMR
(400 MHz, CDCl3): δ 7.37 (ddd, J = 7.8, 6.2, 2.5 Hz, 1H), 7.46−7.53
I
dx.doi.org/10.1021/jo5008064 | J. Org. Chem. XXXX, XXX, XXX−XXX